186P Safety and response to neoadjuvant lenvatinib for poor-prognosis BCLC A hepatocellular carcinoma treated by percutaneous ablation in a curative intent: Preliminary analysis of the French LENVABLA multicentre phase II trial (NCT05113186)
Title:
186P Safety and response to neoadjuvant lenvatinib for poor-prognosis BCLC A hepatocellular carcinoma treated by percutaneous ablation in a curative intent: Preliminary analysis of the French LENVABLA multicentre phase II trial (NCT05113186)
Author:
Nahon, P. Ziol, M. Portal, J-J. Pol, S. Dohan, A. Amadeo, G. Pescatori, L. Brusset, B. Blanc, J.F. Saviano, A. Allaire, M. Vicaut, E. Seror, O.